Published in JAMA on May 14, 1997
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden. BMC Med (2008) 2.47
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention. Cancer Prev Res (Phila) (2008) 2.43
Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. Can Urol Assoc J (2007) 2.04
Risk-based prostate cancer screening. Eur Urol (2011) 1.64
Biomarkers in prostate cancer surveillance and screening: past, present, and future. Ther Adv Urol (2013) 1.48
Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold. Urology (2014) 1.43
The role of an abnormal prostate-specific antigen level and an abnormal digital rectal examination in the diagnosis of prostate cancer: A cross-sectional study in Qatar. Arab J Urol (2013) 1.38
Tumor markers in prostate cancer I: blood-based markers. Acta Oncol (2011) 1.28
Risk stratification in prostate cancer screening. Nat Rev Urol (2012) 1.13
Prostate-specific antigen in the early detection of prostate cancer. CMAJ (2007) 1.13
Screening for prostate cancer: an update. Can J Urol (2008) 1.11
Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach. J Clin Oncol (2010) 1.10
Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels. J Gen Intern Med (2000) 1.02
Nuclear structure as a source of cancer specific biomarkers. J Cell Biochem (2008) 0.97
Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer. Rev Urol (2004) 0.95
Prostate-specific antigen: any successor in sight? Rev Urol (2013) 0.95
Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1-10.0 ng/ml as a criterion. Int J Clin Oncol (2008) 0.95
Predictive Factors for Prostate Cancer in Biopsy of Patients with Prostate-Specific Antigen Levels Equal to or Less Than 4 ng/ml. Korean J Urol (2011) 0.95
Status of radical prostatectomy in 2009: is there medical evidence to justify the robotic approach? Rev Urol (2009) 0.93
Shear wave elastography for detection of prostate cancer: a preliminary study. Korean J Radiol (2014) 0.93
Prostate-specific antigen testing accuracy in community practice. BMC Fam Pract (2002) 0.92
Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel. Cancer Metastasis Rev (2014) 0.89
Image-based clinical decision support for transrectal ultrasound in the diagnosis of prostate cancer: comparison of multiple logistic regression, artificial neural network, and support vector machine. Eur Radiol (2009) 0.89
The effect of walnut intake on factors related to prostate and vascular health in older men. Nutr J (2008) 0.88
PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols. World J Urol (2010) 0.87
Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor. Biosensors (Basel) (2012) 0.86
PSA and beyond: alternative prostate cancer biomarkers. Cell Oncol (Dordr) (2016) 0.86
Vascular targeted photodynamic therapy for localized prostate cancer. Rev Urol (2008) 0.85
Prostate Cancer Education, Detection, and Follow-Up in a Community-Based Multiethnic Cohort of Medically Underserved Men. Am J Mens Health (2015) 0.83
New aspects in shear-wave elastography of prostate cancer. J Ultrason (2015) 0.83
The routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified? Indian J Urol (2009) 0.82
The association of retinoic acid receptor beta2(RARβ2) methylation status and prostate cancer risk: a systematic review and meta-analysis. PLoS One (2013) 0.81
Current early diagnostic biomarkers of prostate cancer. Asian J Androl (2014) 0.81
Carbonic anhydrase I as a new plasma biomarker for prostate cancer. ISRN Oncol (2012) 0.80
Temporal changes in the clinical approach to diagnosing prostate cancer. J Natl Cancer Inst Monogr (2012) 0.80
A Review on the Clinical Utility of PSA in Cancer Prostate. Indian J Surg Oncol (2012) 0.80
Development of a real-time clinical decision support system upon the Web MVC-based architecture for prostate cancer treatment. BMC Med Inform Decis Mak (2011) 0.80
Screening strategies for cancer. Implications and results. JAMA (1997) 0.79
Effect of ejaculation on serum prostate specific antigen level in screening and non-screening population. J Res Med Sci (2013) 0.79
Early detection and aggressive treatment of prostate cancer: groping in the dark. J Gen Intern Med (2000) 0.78
Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage? Eur J Med Res (2011) 0.77
PSA thresholds for prostate cancer detection. JAMA (1997) 0.77
Biopsy follow-up of prostate-specific antigen tests. Am J Prev Med (2012) 0.77
PSA, PSA derivatives, proPSA and prostate health index in the diagnosis of prostate cancer. Turk J Urol (2014) 0.77
Kallikreins as biomarkers for prostate cancer. Biomed Res Int (2014) 0.77
A questionnaire survey of patient preparation and techniques for prostate biopsy among urologists in the Kyushu and Okinawa regions of Japan. Int J Clin Oncol (2006) 0.77
Best screening tests for prostate cancer. West J Med (1998) 0.77
Serum total prostate-specific antigen values in men with symptomatic prostate enlargement in Nigeria: role in clinical decision-making. Clin Interv Aging (2014) 0.77
Urinary Volatile Organic Compounds for the Detection of Prostate Cancer. PLoS One (2015) 0.77
The likelihood of having a serum PSA level of ≥2.5 or ≥4.0 ng ml(-1) according to obesity in a screened Korean population. Asian J Androl (2013) 0.76
Role of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expression. Genes Cancer (2014) 0.76
Management of clinically localized prostate cancer. Rev Urol (2004) 0.75
Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program. PLoS One (2015) 0.75
PSA thresholds for prostate cancer detection. JAMA (1997) 0.75
Prostate-specific antigen testing. Should we recommend it? Can Fam Physician (2003) 0.75
Constitutive and Inducible Expression of Invasion-related Factors in PC-3 Prostate Cancer Cells. J Cancer Prev (2015) 0.75
Prostate carcinoma: clarification through clinical insight and molecular diagnostics. West J Med (1998) 0.75
Patients treated with radical prostatectomy with positive digital rectal examination findings in the intermediate-risk group are prone to PSA recurrence. Oncol Lett (2016) 0.75
PSA thresholds for prostate cancer detection. JAMA (1997) 0.75
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1). Asian J Androl (2015) 0.75
The value of screening tests for detection of prostate cancer in 1000 saudi men. J Family Community Med (2004) 0.75
Molecular Form Differences Between Prostate-Specific Antigen (PSA) Standards Create Quantitative Discordances in PSA ELISA Measurements. Sci Rep (2016) 0.75
Optimizing prostate biopsy strategies for the diagnosis of prostate cancer. Rev Urol (2003) 0.75
Risk calculators and updated tools to select and plan a repeat biopsy for prostate cancer detection. Asian J Androl (2015) 0.75
The importance of screening African Americans for prostate cancer. J Natl Med Assoc (1997) 0.75
Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less. Iran J Public Health (2015) 0.75
Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: the use of PSA derivatives and novel markers. Postgrad Med J (2002) 0.75
Clinicopathological study of 9 cases of prostate cancer involving the rectal wall. Diagn Pathol (2017) 0.75
Effect of ejaculation on Serum Prostate-Specific Antigen concentration. Int Braz J Urol (2016) 0.75
The Combination of Computational and Biosensing Technologies for Selecting Aptamer against Prostate Specific Antigen. Biomed Res Int (2017) 0.75
The role of prostate cancer biomarkers in undiagnosed men. Curr Opin Urol (2017) 0.75
[How to use PSA in 2009]. Wien Med Wochenschr (2009) 0.75
Relationship between prostate-specific antigen levels and ambient temperature. Int J Biometeorol (2013) 0.75
Probability of prostate cancer as a function of the percentage of free prostate-specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4-10 ng/ml. World J Urol (2004) 0.75
Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med (1991) 6.94
Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA (1993) 3.46
NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron (2000) 3.45
Comparison of time-resolved and -unresolved measurements of deoxyhemoglobin in brain. Proc Natl Acad Sci U S A (1988) 3.01
Preemptive epidural analgesia and recovery from radical prostatectomy: a randomized controlled trial. JAMA (1998) 2.74
ECT-induced delirium in depressed patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci (1991) 2.70
Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA (1995) 2.63
Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol (1994) 2.25
Repeatability and validity of a modified activities of daily living (ADL) index in studies of chronic disability. Int Rehabil Med (1979) 2.14
Morphological evidence for the participation of microtubules in axonal transport. Ann N Y Acad Sci (1975) 2.13
The effectiveness of the confidential unit exclusion option. Transfusion (1994) 2.12
Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol (1999) 2.07
Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol (1995) 2.05
New concepts in acute pain therapy: preemptive analgesia. Am Fam Physician (2001) 1.97
Structural cross-bridges between microtubules and mitochondria in central axons of an insect (Periplaneta americana). J Cell Sci (1977) 1.97
Comparison of surgical and anesthetic complications in neurosurgical patients experiencing venous air embolism in the sitting position. Neurosurgery (1986) 1.92
Can I have an ambulance, doctor? Br Med J (1974) 1.90
On the significance of cross-bridges between microtubules and synaptic vesicles. Philos Trans R Soc Lond B Biol Sci (1971) 1.86
Remedial therapy after stroke: a randomised controlled trial. Br Med J (Clin Res Ed) (1981) 1.84
The organization of synaptic axcplasm in the lamprey (petromyzon marinus) central nervous system. J Cell Biol (1970) 1.83
Interlaboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yield comparable diagnostic results. Alzheimer Dis Assoc Disord (1993) 1.72
Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. J Urol (1996) 1.70
A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol (2000) 1.69
Alzheimer's disease and driving: prediction and assessment of driving performance. J Am Geriatr Soc (1997) 1.68
Parkinsonian symptoms during emergence from general anesthesia. Anesthesiology (1995) 1.65
Lower caliceal stone clearance after shock wave lithotripsy or ureteroscopy: the impact of lower pole radiographic anatomy. J Urol (1998) 1.63
The organization and myofilament array of insect visceral muscles. J Cell Sci (1966) 1.57
An approach to proteomic analysis of human tumors. Mol Carcinog (2000) 1.57
Short-wave infrared transfer radiometer for the calibration of the moderate-resolution imaging spectrometer and the advanced spaceborne thermal emission and reflection radiometer. Appl Opt (2000) 1.56
Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth. J Natl Cancer Inst (1997) 1.52
5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol (1994) 1.51
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res (2000) 1.50
Oxidative phosphorylation system during steady-state hypoxia in the dog brain. J Appl Physiol (1985) (1990) 1.48
The effect of oral midazolam on anxiety of preschool children during laceration repair. Ann Emerg Med (1990) 1.46
Estimating lumbar-puncture depth in children. N Engl J Med (1988) 1.45
The organization and function of the sarcoplasmic reticulum and T-system of muscle cells. Prog Biophys Mol Biol (1966) 1.45
Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol (1998) 1.42
Biochemical response to testicular androgen ablation among patients with prostate cancer for whom flutamide and/or finasteride therapy failed. Urology (1998) 1.38
Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide. J Immunol (1987) 1.38
Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores. J Urol (2000) 1.36
Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature (1993) 1.35
Translational control of ribosomal protein L4 mRNA is required for rapid neurite regeneration. Neurobiol Dis (2000) 1.35
Corticosteroids in croup: a chink in the ivory tower? J Pediatr (1989) 1.31
Polarisation fluoroimmunoassay of gentamicin. Clin Chim Acta (1976) 1.27
Assessment of motor function in studies of chronic disability. Rheumatol Rehabil (1980) 1.27
Exocytosis in the adrenal medulla demonstrated by freeze-etching. Science (1973) 1.25
Five-year experience in prehospital intraosseous infusions in children and adults. Ann Emerg Med (1993) 1.25
Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies. J Urol (1997) 1.24
Adult endopyelotomy: impact of etiology and antegrade versus retrograde approach on outcome. J Urol (1998) 1.24
Endothelial projections as revealed by scanning electron microscopy. Science (1971) 1.24
Fluorometric assays for avidin and biotin. Methods Enzymol (1986) 1.22
Measurement of regional cerebral blood flow in cat brain using intracarotid 2H2O and 2H NMR imaging. Magn Reson Med (1990) 1.21
Glucose: a reevaluation of its intraoperative use. Anesthesiology (1987) 1.20
Pediatric intraosseous infusions: impact on vascular access time. Am J Emerg Med (1988) 1.20
Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. J Urol (1994) 1.19
The organization of flight muscle fibers in the Odonata. J Cell Biol (1966) 1.17
Gold-induced thrombocytopenia and response to dimercaprol. Br Med J (1972) 1.13
Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers. J Urol (1997) 1.12
The frozen shoulder: a review of manipulative treatment. Rheumatol Rehabil (1980) 1.11
Using Functional Independence Measure profiles as an index of outcome in the rehabilitation of brain-injured patients. Arch Phys Med Rehabil (1994) 1.10
Human antibodies to phosphocholine. IgG anti-PC antibodies express restricted numbers of V and C regions. J Immunol (1987) 1.10
Linear regression analysis by Deming's method. Clin Chem (1980) 1.09
Manipulation for chronic neck pain. A double-blind controlled study. Spine (Phila Pa 1976) (1983) 1.09
Actin-myosin interaction. Self-assembly into a bipolar "contractile unit". J Mol Biol (1977) 1.07
The treatment of idiopathic thrombocytopenia with vinblastine-loaded platelets. N Engl J Med (1978) 1.05
Characterization of a nerve growth factor-stimulated protein kinase in PC12 cells which phosphorylates microtubule-associated protein 2 and pp250. J Neurochem (1990) 1.04
The structure of intersegmental muscle fibers in an insect, Periplaneta americana L. J Cell Biol (1966) 1.04
Acute pancreatitis and haemolytic anaemia associated with mumps-virus infection. Br Med J (1965) 1.04
Alveolar type II cells: studies on the mode of release of lamellar bodies. Tissue Cell (1975) 1.04
Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels. J Urol (1997) 1.04
Freeze-etch studies of the plasma membrane of pulmonary endothelial cells. J Cell Biol (1973) 1.03
Structural features associated with movement and 'catch' of sea-urchin spines. Tissue Cell (1981) 1.03
The organization of flight muscle in an aphid, Megoura viciae (Homoptera). With a discussion on the structure of synchronous and asynchronous striated muscle fibers. J Cell Biol (1965) 1.03
Escherichia coli bacteremia in children. A review of 91 cases in 10 years. Am J Dis Child (1991) 1.02
Zinc gluconate and the common cold: a controlled clinical study. J Int Med Res (1992) 1.01
Structural modulations in the tsetse fly milk gland during a pregnancy cycle. Tissue Cell (1975) 1.00
Freeze-fractured lamellar body membranes of the rat lung great alveolar cell. Tissue Cell (1972) 1.00
Molecular profiling of clinical tissue specimens: feasibility and applications. Am J Pathol (2000) 1.00
Blunt splenic injuries: dedicated trauma surgeons can achieve a high rate of nonoperative success in patients of all ages. J Trauma (2000) 1.00
Stability of serum total and free prostate specific antigen under varying storage intervals and temperatures. J Urol (1997) 0.99
Recurrence phenotypes and establishment of latency following rabbit keratitis produced by multiple herpes simplex virus strains. J Gen Virol (1983) 0.99
Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy. J Urol (1996) 0.99
The effects of high-dose fentanyl on cerebral circulation and metabolism in rats. Anesthesiology (1982) 0.99
The effects of depression and abnormal illness behaviour on outcome following rehabilitation from stroke. Clin Rehabil (1998) 0.98
Abnormal illness behaviour in rehabilitation from stroke. Clin Rehabil (1997) 0.98
Molecular profiling of clinical tissues specimens: feasibility and applications. J Mol Diagn (2000) 0.98
Influence of complete and pronounced incomplete cerebral ischemia and subsequent recirculation on cortical concentrations of oxidized and reduced glutathione in the rat. J Neurochem (1980) 0.98
Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. Ann Rheum Dis (1982) 0.97
Effect of ejaculation on serum total and free prostate-specific antigen concentrations. Urology (1997) 0.97
Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less. J Urol (1999) 0.97
The effect of breast-feeding on the antibody response of infants to trivalent oral poliovirus vaccine. J Pediatr (1973) 0.96
Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors. AIDS (2001) 0.95
Elevated liver transaminase levels in children with blunt abdominal trauma: a predictor of liver injury. Pediatrics (1990) 0.95
Postsynaptic membranes in the electric tissue of Narcine: IV. Isolation and characterization of the nicotinic receptor protein. Tissue Cell (1977) 0.94
Distinguishing cerebrospinal fluid abnormalities in children with bacterial meningitis and traumatic lumbar puncture. J Infect Dis (1990) 0.94
Cell surface electrochemical heterogeneity of the Fe(III)-reducing bacteria Shewanella putrefaciens. Environ Sci Technol (2001) 0.94
Estimation of serum gentamicin by quenching fluoroimmunoassay. J Clin Pathol (1977) 0.94
On-road assessment of driving competence after brain impairment: review of current practice and recommendations for a standardized examination. Arch Phys Med Rehabil (1998) 0.93